- Home
- MTVA vs MODV Comparison
MTVA vs MODV Comparison
Compare MTVA & MODV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MTVA
- MODV
- Stock Information
- Founded
- MTVA 2014
- MODV 1996
- Country
- MTVA United States
- MODV United States
- Employees
- MTVA N/A
- MODV N/A
- Industry
- MTVA
- MODV Transportation Services
- Sector
- MTVA
- MODV Consumer Discretionary
- Exchange
- MTVA NYSE
- MODV Nasdaq
- Market Cap
- MTVA 13.6M
- MODV 16.1M
- IPO Year
- MTVA N/A
- MODV N/A
- Fundamental
- Price
- MTVA $0.78
- MODV $1.36
- Analyst Decision
- MTVA Strong Buy
- MODV Buy
- Analyst Count
- MTVA 1
- MODV 4
- Target Price
- MTVA $12.00
- MODV $8.38
- AVG Volume (30 Days)
- MTVA 1.4M
- MODV 442.9K
- Earning Date
- MTVA 05-08-2025
- MODV 05-05-2025
- Dividend Yield
- MTVA N/A
- MODV N/A
- EPS Growth
- MTVA N/A
- MODV N/A
- EPS
- MTVA N/A
- MODV N/A
- Revenue
- MTVA N/A
- MODV $2,787,586,000.00
- Revenue This Year
- MTVA N/A
- MODV N/A
- Revenue Next Year
- MTVA N/A
- MODV $5.65
- P/E Ratio
- MTVA N/A
- MODV N/A
- Revenue Growth
- MTVA N/A
- MODV 1.32
- 52 Week Low
- MTVA $0.71
- MODV $0.96
- 52 Week High
- MTVA $5.30
- MODV $32.82
- Technical
- Relative Strength Index (RSI)
- MTVA N/A
- MODV 40.35
- Support Level
- MTVA N/A
- MODV $1.10
- Resistance Level
- MTVA N/A
- MODV $1.34
- Average True Range (ATR)
- MTVA 0.00
- MODV 0.19
- MACD
- MTVA 0.00
- MODV 0.11
- Stochastic Oscillator
- MTVA 0.00
- MODV 80.00
About MTVA METAVIA INC
MetaVia Inc Formerly NeuroBo Pharmaceuticals Inc is a clinical-stage biotechnology company focused predominantly on developing and commercializing novel pharmaceuticals to treat cardiometabolic diseases. The company has two primary programs focused on the treatment of metabolic dysfunction-associated steatohepatitis (MASH), and obesity. Its product pipeline includes DA-1241 which is a novel G-Protein-Coupled Receptor 119 (GPR119) and DA-1726 which is a novel oxyntomodulin (OXM) analog. The company also has four legacy therapeutics programs designed to impact a range of indications in viral, neurodegenerative, and cardiometabolic diseases: ANA001, NB-01, NB-02, and Gemcabene.
About MODV ModivCare Inc.
ModivCare Inc is a technology-enabled healthcare services company that provides a suite of integrated supportive care solutions for payors and their members. Its solutions address the social determinants of health (SDoH) by connecting members to essential care services. Its various service offerings include non-emergency medical transportation, personal care, virtual and remote monitoring, consumer health engagement, and integrated supportive care. The company's reportable segments are NEMT, PCS, Monitoring, and Corporate and Other. A majority of its revenue is generated from the NEMT segment, which provides non-emergency medical transportation services.